Justices Ask SG To Weigh In On GSK, Classen Patent Row
The U.S. Supreme Court on Monday invited the U.S. solicitor general to weigh in on Classen Immunotherapies Inc.'s dispute with GlaxoSmithKline PLC over Classen's patents for evaluating a vaccine immunization schedule....To view the full article, register now.
Already a subscriber? Click here to view full article